Download PDF
Thromb Haemost 1982; 47(03): 278-284
DOI: 10.1055/s-0038-1657185
Original Article
Schattauer GmbH Stuttgart

Desensitisation in Human and Rabbit Blood Platelets

T J Hallam
The Department of Biochemistry, University of London, King's College, London, U. K.
,
P A Ruggles
The Department of Biochemistry, University of London, King's College, London, U. K.
,
M C Scrutton
The Department of Biochemistry, University of London, King's College, London, U. K.
,
R B Wallis
**   The Ciba-Geigy Pharmaceuticals Division, Horsham, West Sussex, U. K.
› Author Affiliations
Further Information

Publication History

Received 29 September 1981

Accepted 29 April 1982

Publication Date:
13 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

1. Exposure of human and rabbit blood platelets to all full agonists tested induces agonist-specific (or homologous) desensitisation except in the case of adrenaline and collagen in human platelets.

2. Desensitisation to vasopressin and 5-hydroxytryptamine (5HT) develops rapidly and results from suppression of maximal responsiveness without significant shift in the dose/response curve (Type I). In rabbit platelets, maintenance of desensitisation to 5HT is correlated with the extracellular 5HT concentration. Responsiveness to other agonists is either unaffected, or is enhanced due to a shift in the dose/response curve to the left without change in maximal responsiveness.

3. Homologous desensitisation to ADP, U-46619 and thrombin develops more slowly, is correlated with disaggregation and is associated with a shift in the dose/response curve to the right without suppression of maximal responsiveness (Type II). Responsiveness to most other agonists is either unaffected, or is enhanced due to a shift in the dose/response curve to the left without a change in maximal responsiveness. However, exposure to thrombin suppresses the maximal response to vasopressin without a shift in the dose/response curve, and exposure to U-46619 causes a shift in the dose/response curve for collagen to the right.

4. In human platelets prolonged exposure to 5HT causes agonist non-specific (or heterologous) desensitisation in which responsiveness to all agonists except adrenaline is suppressed as a result of shifts in the dose/response curves to the right.

5. We propose that Types I and II homologous desensitisation result respectively from prolonged receptor occupancy and from either activation of degradative mechanisms for the agonist or processing of the receptor to a lower affinity state.

Key words

Desensitisation - Platelet aggregation - Argipressin - Serotonin - Prostaglandin endoperoxide analogue - Thrombin - Adenosine diphosphate
 

  • References

  • 1 Raff M. Self-regulation of membrane receptors. Nature 1976; 259: 256-266
    PubMedGoogle Scholar
  • 2 O’Brien Jr. Platelet aggregation. Part. II. Some results from a new method of study. J Clin Pathol 1962; 15: 452-455
    CrossrefPubMedGoogle Scholar
  • 3 Rozenberg MC, Holmsen H. Adenine nucleotide metabolism of blood platelets. II. Uptake of adenosine and inhibitors of ADP-induced platelet aggregation. Biochim Biophys Acta 1968; 155: 342-352
    CrossrefPubMedGoogle Scholar
  • 4 Holme S, Holmsen H. ADP-induced refractory state of platelets in vitro. I. Methodological studies on aggregation in platelet-rich plasma. Scand J Haematol 1975; 15: 96-103
    PubMedGoogle Scholar
  • 5 Holme S, Sixma JJ, Wester J, Holmsen H. ADP-induced refractory state of platelets in vitro. II. Functional and ultra-structural studies on gel-filtered platelets. Scand J Haematol 1977; 18: 267-278
    PubMedGoogle Scholar
  • 6 Baumgartner HR, Born GVR. Effects of 5-hydroxytryptamine on platelet aggregation. Nature 1968; 218: 137-141
    CrossrefPubMedGoogle Scholar
  • 7 Evans RJ, Gordon JL. Refractoriness in blood platelets. Effect of prior exposure to aggregating agents on subsequent aggregation responses. Br J Pharmacol 1974; 51: 123
    PubMedGoogle Scholar
  • 8 Cooper B, Handin RI, Young LH, Alexander RW. Agonist regulation of the human platelet α-adrenergic receptor. Nature 1978; 274: 703-706
    CrossrefPubMedGoogle Scholar
  • 9 Ruggles PA, Scrutton MC. Tachyphylaxis in human blood platelets induced by various agonists and the effect on response to other agonists. Thromb Haemostas 1979; 42: 299 (Abstr.)
    PubMedGoogle Scholar
  • 10 Pearce PH, Wright JM, Egan CM, Scrutton MC. Interaction of human blood platelets with the 2’, 3’-dialdehyde and 2’, 3’-dialcohol derivatives of adenosine 5’-diphosphate and adenosine 5’-triphosphate. Eur J Biochem 1978; 88: 543-554
    CrossrefPubMedGoogle Scholar
  • 11 Wallis RB. The role of prostaglandins in the ADP-induced aggregation of rabbit platelets shown by the use of 15-hydroxyprostaglandin dehydrogenase. Thromb Haemostas 1978; 39: 725-732
    PubMedGoogle Scholar
  • 12 Butler KD, Wallis RB, White AM. A study of the relationship between ex vivo and in vivo effects of sulphinpyrazone in the guinea pig. Haemostasis 1979; 8: 353-360
    PubMedGoogle Scholar
  • 13 Taylor DG, Crawford N. An automated procedure for the extraction and fluorimetrie determination of 5HT in platelet sub-cellular fractions. Anal Biochem 1974; 59: 1-10
    CrossrefPubMedGoogle Scholar
  • 14 Maickel RP, Miller FP. Fluorescent products formed by reaction of indole derivatives and orthophthaldialdehyde. Anal Chem 1966; 38: 1937-1445
    CrossrefPubMedGoogle Scholar
  • 15 Huidobro-Toro JP, Foree B. Dual agonist-antagonist effects of 5-hydroxytryptamine in the guinea pig ileum: Evidence for a selective receptor desensitisation effect. Eut J Pharmacol 1980; 61: 335-345
    PubMedGoogle Scholar
  • 16 Tollefsen DM, Majerus PW. Evidence for a single class of thrombin-binding sites on human platelets. Biochemistry 1976; 15: 2144-2149
    CrossrefPubMedGoogle Scholar
  • 17 Tam SW, Fenton JW, Detwiler TC. Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing. J Biol Chem 1979; 254: 8723-8725
    PubMedGoogle Scholar
  • 18 Packham MA, Kinlough-Rathbone RL, Reimers HJ, Scott S, Mustard JF. Mechanisms of platelet aggregation independent of adenosine diphosphate. In Prostaglandins in Hematology. Smith JB, Silver MJ, Kocsis JJ. (eds.) 247-276 Spectrum Publications Inc.; New York: 1977
    Google Scholar
  • 19 Charo IF, Feinman RD, Detwiler TC, Smith JB, Ingerman CM, Silver MJ. Prostaglandin endoperoxides can induce platelet aggregation in the absence of secretion. Nature 1977; 269: 66-69
    CrossrefPubMedGoogle Scholar
  • 20 Charo IF, Feinman RD, Detwiler TC. Interrelations of platelet aggregation and secretion. J Clin Invest 1977; 60: 866-873
    CrossrefPubMedGoogle Scholar
  • 21 Marcus AJ. The role of lipids in platelet function: with particular reference to the arachidonate pathway. J Lipid Res 1978; 19: 793-826
    PubMedGoogle Scholar
  • 22 Haslam RJ. Roles of cyclic nucleotides in platelet function. CIBA Foundation Symposium 1975; 35 new series 121-143
    PubMedGoogle Scholar
  • 23 Harris DN, Phillips MB, Goldenberg HJ. Effect of substituted purines of the inhibition by PGE1 of ADP-induced aggregation of human platelets and on the increase in cyclic AMP induced in platelets by PGE1 . Fed Proc 1975; 34: 617
    PubMedGoogle Scholar
  • 24 Putney JW. Role of calcium in the fade of the potassium response in the rat parotid gland. J Physiol (Lond) 1978; 281: 383-394
    CrossrefPubMedGoogle Scholar
  • 25 Berridge MJ, Fain JNL. Inhibition of phosphatidylinositol synthesis and the inactivation of calcium entry after prolonged exposure of the blowfly salivary gland to 5-hydroxytryptamine. Biochem J 1979; 178: 59-69
    CrossrefPubMedGoogle Scholar
  • 26 MacIntyre DE. Platelet prostaglandin receptors. In Platelets in Biology and Pathology 2. Gordon JL. (ed.) 211-247 Elsevier/North Holland Biomedical Press; Amsterdam: 1981
    Google Scholar
  • 27 Malmsten C. Some biological effects of prostaglandin endoperoxide analogues. Life Sci 1976; 18: 169-176
    CrossrefPubMedGoogle Scholar
  • 28 Coleman RA, Humphrey PPA, Kennedy I, Levy GP, Lumley P. U-46619, a selective thromboxane A2-like agonist?. Br J Pharmacol 1980; 68: 127-128
    PubMedGoogle Scholar
  • 29 Grant JA, Scrutton MC. Interaction of selective α-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Br J Pharmacol 1980; 71: 121-134
    CrossrefPubMedGoogle Scholar
  • 30 Markwardt F, Glusa E, Barthel W. Influence of dihydroergotoxine on platelet aggregation in rabbits. Thromb Res 1977; 10: 783-789
    CrossrefPubMedGoogle Scholar
  • 31 Holmes IB. Potentiating effect of adrenaline on adenosine diphosphate - induced reduction in rabbit circulating platelet count: Inhibition by dihydroergotoxine. Thromb Haemostas 1979; 42: 641-648
    PubMedGoogle Scholar
  • 32 Doni MG, Aragno R. Effect of catecholamines on ADP aggregation of rat platelets in vivo. Experentia 1977; 33: 1331-1322
    CrossrefPubMedGoogle Scholar
  • 33 Jørgensen L, Rowsell HC, Hovig T, Glynn MF, Mustard JF. Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Lab Invest 1967; 17: 616-644
    PubMedGoogle Scholar